XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHea... ( SURESNES France and ISMANING Germ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market

Date:10/16/2008

SURESNES, France and ISMANING, Germany, Oct. 17 /PRNewswire-FirstCall/ -- XIRING (NYSE Alternext: ALXIR), a European leader in security solutions for remote transactions, and SCM Microsystems (Nasdaq: SCMM; Prime Standard: SMY), a leading provider of solutions that open the Digital World, today announced their close collaboration to develop mobile eHealth smart card terminals for the new generation German healthcare system. Beginning in late 2008, new electronic health insurance cards will be distributed to 82 million German citizens, creating a market for compatible mobile eHealth terminals that facilitate at-home patient consultation and treatment by Germany's 310,000 healthcare professionals and 130,000 physiotherapists. With this agreement, the two companies aim to achieve a leading share of this new market. SCM will sell the mobile terminals in Germany through its existing distribution channels and Value Added Partners.

XIRING, the leader of the French healthcare terminal market (SESAM-Vitale scheme), brings strong technical and field experience to the collaboration, highlighted by its robust mobile platform for healthcare professionals that is widely deployed in France. SCM Microsystems has developed several generations of proto-type and market-ready desktop eHealth terminals based on its close, multi-year collaboration with gematik, the German healthcare organization overseeing the country's eHealth scheme, and the German Federal Office of Information Technology, BSI (Bundesamt fur Sicherheit in der Informationstechnologie), in charge of defining security requirements for the program. XIRING and SCM are uniquely qualified to address the demanding technical specifications and strict security targets for mobile terminals in the German program.

"XIRING has the broadest range of healthcare solutions in France and their products are well recognised for their quality, performance and ergonomics. XIRING's experience makes them an ideal partner t
'/>"/>

SOURCE SCM Microsystems; XIRING
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Agfa HealthCare, InterComponentWare, and Sun Microsystems Join Open eHealth Foundation at HIMSS08
2. e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification
3. CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems
4. 3rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide, Inc.
5. Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd.
6. PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File
7. Perth Leadership Institute Issues Alert on the Post-Crash Environment Facing HR/Leadership Development
8. Children as Young as 4 Can Develop OCD
9. HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device
10. 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program
11. CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinsons Disease

Post Your Comments:

(Date:11/25/2009)...draw definite conclusions, experts say, , ...betic patients with blocked coronary arteries, the...year whether patients undergo bypass surgery or an...t. , Bypass surgery has been the standard treat...sease. However, less invasive approaches such as a...

(Date:11/25/2009)...atment clinics to resume Monday, Nov. 30 , ...009 -- Centegra Health System is continuing to off...our Centegra Primary Care (CPC) vaccination clinic...he clinics are at CPC sites in Huntley, Woodstock,...ows: , From 4:30 to 7:30 p.m. Tuesda...

(Date:11/25/2009)...toms, study finds , , WEDNESDAY, Nov. 2...e among the potential problems faced by long-term ...th cisplatin-based chemotherapy, a new study has f...treated for unilateral testicular cancer between 1...onducted from 1998 to 2002. , The researchers f...

(Date:11/25/2009)...Skincare ®isproudtosupportGNC,seffortstoraise...Jude ThanksandGiving campaign,$1fromthepurchasepri...lm willbedonatedtoSt.Jude.Additionally,GNCcustomer...koutatoneoftheir5,000+retaillocationsoratGNC.com.G...ir2009 ThanksandGiving campaign. ,, "Wearedelig...

(Date:11/25/2009)...aightYear ,, WASHINGTON,Nov.25/PRNewswire-USN...A)issuedthe 4thAnnualReportCardonLungCancer .ThisR...ethaldiseaseinthestateofGeorgia.LCA-GAisachapterof...ndedicatedexclusivelytopatientsupportandadvocacyfo...o: http://www.newscom.com/cgi-bin/prnh/20081016/LC...

Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3 Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4 Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2 Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2

[0] Stenting May Equal Bypass for Diabetic Heart Patients [0] Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 [0] Long-Term Problems Linked to Testicular Cancer Chemo [2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)[0] Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer

...eanwhile, U.S. officials say there,s no longer a n...UESDAY, May 5 (HealthDay News) -- A Texas woman wh...nic health problems died this week after contracti...he first death of a Texas resident with H1N1 flu,"...

... Alice Stollenwerk Petrul...ne Peer Review Organizations, Inc. (KePRO), an int...ganization, will be a featured speaker at the 15th...ollenwerk Petrulis, MD, FACP, Chief Medical Office...

... Researchers at University of Florida -- G...ia -- Los Angeles to Receive $250,000 ...DDLETOWN, Ohio, May 5 Patricia A. Furlong, Foundi...or Duchenne muscular dystrophy (Duchenne), announc...

... First Shareholder Meeting Since Split Draws Globa...o deaths climbing above 5.4 million a year, Philip...rcent net revenue growth in 2008. Not coincidental... the end of PMI,s 2008 surge, the international co...

...onikers seem to get staying power from slow growth...ay News) -- Faddish baby names don,t retain their ...that take their time becoming popular seem most ap... fads and prefer the tried and true, said the stud...

... Children,s National Medi...hensive Media Room on May 1, 2009. , ...National Medical Center dedicated the Paul Franci...l and Barbara Hills in honor of Paul Francis Baier...

Texas Officials Report 2nd Swine Flu Death in U.S.Alice Stollenwerk Petrulis, MD, FACP, to Speak at 15th Annual MEDecision User Conference Parent Project Muscular Dystrophy Awards Two End Duchenne Grants Corporate Accountability International: Tobacco Giant Leads in Profits, Addicting Youth Fad Baby Names Tend to Fizzle Fast Baier Media Room Advances Critical Care At Children's National Medical Center

(Date:11/25/2009)..., BEDFORD,Mass.,Nov.25/PRNewswire-FirstCall/--H...eadingdeveloper,manufacturerandsupplierofpremiumdi...dedicatedtoservingthehealthcareneedsofwomen,isusin...erica(RSNA)atMcCormickPlaceinChicago,November29thr...;)DXmultimodalitydiagnosticmammographyworkstations...

(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResear...: Stelara report,thefirstinamulti-phasesyndicate...rtho-Biotech,sStelara,fromproductlaunchthroughthef...videsquantitativeinformationfrom75uniqueDermatolog...portsassesstrialanduseofStelara,obstaclestouse,typ...

(Date:11/25/2009)..., RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPA...cCorporation(Nasdaq: APFC )announcedtodaythatitrec...tyAwardattheAnnualStatewideEnvironmentalSummit,spo...ociation(CMTA),theIndustrialEnvironmentalAssociati...ICC)heldinSanDiego.Thisisthemostprestigiousawardav...

Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3 Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2 AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2 Womens Sexual Health Company Changes Name in Preparation for Market Entry 6092 1 Womens Sexual Health Company Changes Name in Preparation for Market Entry 6092 2 Milestone Scientific to Exhibit at the 15th Anniversary of TBSE 28The Best Seminar Ever 29 in Las Vegas 6089 1 Milestone Scientific to Exhibit at the 15th Anniversary of TBSE 28The Best Seminar Ever 29 in Las Vegas 6089 2 TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 10657 1 TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 10657 2

[0] New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity [0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High [0] AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit

...ration Will Seek to Identify Unique microRNA Signa...ce in Lung Cancer Patients,The Project Will Levera...on, and Quantification Technologies, and M. D. An...perience in Lung Cancer Research, Test Will be Des...gh Risk, of Recurrence, who may Benefit From Adju...

...NCISCO, June 6 OxyBand Technologies Inc., San,Fra...ompany,s bio-medical,technology development and ex.... OxyBand develops innovative therapeutic gas tech... company,s inaugural device is an,oxygen wound hea...over the,counter marketing. OxyBand has received a...

Other Medicine Technology:Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 2 Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 3 Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 4 Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 5 OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer 2

Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

Medicine Products:

Arbovirus Antibodies, IgM by IFA, Serum Aprobarbital, Urine Arbovirus Antibodies, IgG by IFA, CSF Apresoline

XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHea...( SURESNES France and ISMANING Germ...),Health